Endothelin-1 Augments Na+/H+ Exchange Activity in Murine Pulmonary Arterial Smooth Muscle Cells via Rho Kinase
Open Access
- 28 September 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (9) , e46303
Abstract
Excessive production of endothelin-1 (ET-1), a potent vasoconstrictor, occurs with several forms of pulmonary hypertension. In addition to modulating vasomotor tone, ET-1 can potentiate pulmonary arterial smooth muscle cell (PASMC) growth and migration, both of which contribute to the vascular remodeling that occurs during the development of pulmonary hypertension. It is well established that changes in cell proliferation and migration in PASMCs are associated with alkalinization of intracellular pH (pHi), typically due to activation of Na+/H+ exchange (NHE). In the systemic vasculature, ET-1 increases pHi, Na+/H+ exchange activity and stimulates cell growth via a mechanism dependent on protein kinase C (PKC). These results, coupled with data describing elevated levels of ET-1 in hypertensive animals/humans, suggest that ET-1 may play an important role in modulating pHi and smooth muscle growth in the lung; however, the effect of ET-1 on basal pHi and NHE activity has yet to be examined in PASMCs. Thus, we used fluorescent microscopy in transiently (3–5 days) cultured rat PASMCs and the pH-sensitive dye, BCECF-AM, to measure changes in basal pHi and NHE activity induced by increasing concentrations of ET-1 (10−10 to 10−8 M). We found that application of exogenous ET-1 increased pHi and NHE activity in PASMCs and that the ET-1-induced augmentation of NHE was prevented in PASMCs pretreated with an inhibitor of Rho kinase, but not inhibitors of PKC. Moreover, direct activation of PKC had no effect on pHi or NHE activity in PASMCs. Our results indicate that ET-1 can modulate pH homeostasis in PASMCs via a signaling pathway that includes Rho kinase and that, in contrast to systemic vascular smooth muscle, activation of PKC does not appear to be an important regulator of PASMC pHi.Keywords
This publication has 71 references indexed in Scilit:
- Amiloride Analogs Inhibit Chronic Hypoxic Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Growth Factors Mediate Intracellular Signaling in Vascular Smooth Muscle Cells Through Protein Kinase C–Linked PathwaysHypertension, 1997
- pH and smooth muscle1997
- Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1997
- The Orally Active Nonpeptide Endothelin A-Receptor Antagonist A-127722 Prevents and Reverses Hypoxia-Induced Pulmonary Hypertension and Pulmonary Vascular Remodeling in Sprague-Dawley RatsJournal of Cardiovascular Pharmacology, 1997
- Endothelin: Systemic Arterial and Pulmonary Effects of a New Peptide with Potent Biologic PropertiesAmerican Review of Respiratory Disease, 1992
- Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1992
- Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.Circulation, 1992
- Contribution of Na+/H+ Exchange to pH Regulation in Pulmonary Artery Smooth Muscle CellsAmerican Journal of Respiratory Cell and Molecular Biology, 1991
- Proliferation and Na+/H+ Exchange Activation by Endothelin in Vascular Smooth Muscle CellsAmerican Journal of Hypertension, 1991